CO2-Fixing One-Carbon Metabolism in a Cellulose-Degrading Bacterium

Total Page:16

File Type:pdf, Size:1020Kb

CO2-Fixing One-Carbon Metabolism in a Cellulose-Degrading Bacterium CO2-fixing one-carbon metabolism in a cellulose- degrading bacterium Clostridium thermocellum Wei Xionga, Paul P. Linb, Lauren Magnussona, Lisa Warnerc, James C. Liaob,d, Pin-Ching Manessa,1, and Katherine J. Choua,1 aBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401; bDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095; cNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO 80401; and dAcademia Sinica, Taipei City, Taiwan 115 Edited by Lonnie O. Ingram, University of Florida, Gainesville, FL, and approved September 23, 2016 (received for review April 6, 2016) Clostridium thermocellum can ferment cellulosic biomass to for- proposed pathway involving CO2 utilization in C. thermocellum is mate and other end products, including CO2. This organism lacks the malate shunt and its variant pathway (7, 14), in which CO2 is formate dehydrogenase (Fdh), which catalyzes the reduction of first incorporated by phosphoenolpyruvate carboxykinase (PEPCK) 13 CO2 to formate. However, feeding the bacterium C-bicarbonate to form oxaloacetate and then is released either by malic enzyme or and cellobiose followed by NMR analysis showed the production via oxaloacetate decarboxylase complex, yielding pyruvate. How- of 13C-formate in C. thermocellum culture, indicating the presence ever, other pathways capable of carbon fixation may also exist but of an uncharacterized pathway capable of converting CO2 to for- remain uncharacterized. mate. Combining genomic and experimental data, we demon- In recent years, isotopic tracer experiments followed by mass strated that the conversion of CO2 to formate serves as a CO2 spectrometry (MS) (15, 16) or NMR measurements (17) have entry point into the reductive one-carbon (C1) metabolism, and emerged as powerful tools for metabolic analysis. This methodol- internalizes CO2 via two biochemical reactions: the reversed pyru- ogy traces the transit of isotopic atoms throughout the biochemical vate:ferredoxin oxidoreductase (rPFOR), which incorporates CO2 network and sheds light on active reactions as well as molecular using acetyl-CoA as a substrate and generates pyruvate, and py- fluxes in vivo. Coupled with classic genetic manipulations, this ruvate-formate lyase (PFL) converting pyruvate to formate and technology has been successfully applied to provide insights into acetyl-CoA. We analyzed the labeling patterns of proteinogenic novel metabolic pathways in bacteria (18), yet it has not been used MICROBIOLOGY amino acids in individual deletions of all five putative PFOR mu- to study C. thermocellum. tants and in a PFL deletion mutant. We identified two enzymes In several species of Clostridium, the one-carbon (C1) metabolism acting as rPFOR, confirmed the dual activities of rPFOR and PFL is initiated from CO2 reduction to become formate via formate crucial for CO2 uptake, and provided physical evidence of a distinct dehydrogenase (Fdh) (19). This pathway provides C1 units for many “ ” in vivo rPFOR-PFL shunt to reduce CO2 to formate while circum- crucial reactions, including amino acids and purine biosynthesis. venting the lack of Fdh. Such a pathway precedes CO2 fixation via Formate serves as a precursor to the folate biosynthesis pathway that the reductive C1 metabolic pathway in C. thermocellum. These forms the “methyl” branch of the Wood–Ljungdahl pathway, yield- C. thermocel- findings demonstrated the metabolic versatility of ing acetyl-CoA from CO2 (19). However, C. thermocellum lacks the lum, which is thought of as primarily a cellulosic heterotroph but is first key enzyme, Fdh, based on genome information. In the pre- shown here to be endowed with the ability to fix CO2 as well. sent study, we investigate CO2-fixing pathway(s) in C. thermocellum involving C1 metabolism by using 13C-tracer experiments. We Clostridium thermocellum | pyruvate:ferredoxin oxidoreducase | formate | 13 C-isotopic tracing | one-carbon metabolism Significance he gram-positive Clostridium thermocellum is a thermophilic High carbon yield in the bioengineering of heterotrophic and strict anaerobic bacterium. It has gained a great amount T bacteria is hindered by carbon loss to CO2 production. We of interest due to its cellulolytic abilities. By taking advantage provide evidence showing Clostridium thermocellum, a cellulose- of an extracellular cellulase system called the cellulosome (1), degrading bacterium and a model consolidated bioprocessing C. thermocellum can depolymerize cellulose into soluble oligo- organism, can fix CO2 while growing predominantly on cellobi- saccharides. The latter are further transported into the cells and ose, a cellulose-derived disaccharide. By adding 13C-bicarbonate fermented through its glycolytic pathway to pyruvate, the pre- to the bacterial culture and tracking 13C-labeled metabolites, we cursor to an array of fermentation products (e.g., H2, formate, discovered active reductive one-carbon (C1) metabolism in this lactate, acetate, ethanol, secreted amino acids) (2, 3). This ca- bacterium. We further identified critical enzymes responsible for pability makes C. thermocellum an attractive candidate for con- fixing CO2 and channeling the fixed carbon to the C1 metabolic solidated bioprocessing of lignocellulosic biomass, a process pathway. Our findings pave the way to future engineering of this configuration that directly converts plant biomass into biofuels bacterium to use cellulose and CO2 simultaneously as a means to and chemicals without separate additions of enzymes (4). To date, improve microbial carbon efficiency that is constrained by theo- there have been numerous works describing the molecular and retical limitation and to reduce CO2 in the environment. genetic details of the cellulolytic system and fermentation path- ways in C. thermocellum (5–9), whereas other metabolic charac- Author contributions: W.X., P.P.L., L.M., L.W., J.C.L., P.-C.M., and K.J.C. designed research; W.X., P.P.L., L.M., L.W., and K.J.C. performed research; W.X., P.P.L., L.M., L.W., J.C.L., P.-C.M., teristics of this species have not been adequately understood. and K.J.C. analyzed data; and W.X., P.P.L., L.M., L.W., J.C.L., P.-C.M., and K.J.C. wrote Currently, few details regarding inorganic carbon utilization the paper. are known for C. thermocellum. However, several investigators The authors declare no conflict of interest. routinely add bicarbonate, a dissolved form of CO2,intotheme- This article is a PNAS Direct Submission. – dium to promote C. thermocellum growth (6, 10 12), implying its Freely available online through the PNAS open access option. ability to use CO . This observation raises the questions of how 1 2 To whom correspondence may be addressed. Email: [email protected] or pinching. CO2 plays a role in promoting C. thermocellum growth (13), and [email protected]. whether CO2 is incorporated into the metabolism. There is limited This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. information on pathways relating to CO2 uptake thus far. One 1073/pnas.1605482113/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1605482113 PNAS Early Edition | 1of6 measure the isotopomers of fermentation products and proteino- media and did not change in relative intensity from sample genic amino acids using NMR and GC/MS, and uncover a route to sample. C. thermocellum employs to fix CO2 when grown in a primarily heterotrophic mode supplemented with sodium bicarbonate. Putative Reductive C1 Metabolism Based on Genome Annotation. The above labeling experiments provided evidence of a significant CO2-to- Results formate reduction pathway that remains to be characterized. To Effects of Bicarbonate on C. thermocellum Growth and Metabolism. identify genes that are putatively responsible for this conversion, To examine C. thermocellum’s ability to use inorganic carbon, we we reconstructed the C1 metabolic pathway de novo, based compared cell growth and metabolic product formation during on the genomic information of C. thermocellum DSM1313 strain cellobiose fermentation with and without bicarbonate supple- (20). Its genome sequence suggests that C. thermocellum is ca- mentation (20 mM). To eliminate any potential buffering effect pable of converting formate to methionine, serine, and pyruvate exerted by bicarbonate, fermentation was performed in batch via the methyl branch of the Wood–Ljungdahl pathway (Fig. 2). mode with pH controlled at 7.0 throughout. Upon consumption However, it lacks Fdh, the enzyme microbes typically use to of all cellobiose, cultures with added bicarbonate yielded ∼40% convert CO2 to formate (Fig. 2). more cell biomass than in its absence (Table 1). Without ac- Lacking the fdh gene, the only other gene encoding formate counting for the excreted amino acids that have been observed in production found in C. thermocellum genome is pyruvate-formate overflow metabolism (3), this result increased the possibility that lyase (PFL), catalyzing the conversion of pyruvate and CoA to extra total carbon output (i.e., cell biomass, lactate) could emerge acetyl-CoA and formate (21). We thereby hypothesize that a by- from incorporation of the inorganic carbon (bicarbonate) as sug- pass consisting of two reactions catalyzed by pyruvate:ferredoxin gested by the calculated apparent carbon efficiency (65.7% with- oxidoreductase (PFOR) in the reversed direction and PFL may out bicarbonate and 75.5% with bicarbonate; Table 1). We also realize the CO2-to-formate conversion. Presumably, the
Recommended publications
  • Electromicrobial Transformations Using the Pyruvate Synthase System of Clostridium Sporogenes
    I I I 1 Bioelec~rochemistryand Bioenergetics, 21 (1989) 245-259 A section of J. Electroanal. Cheni., and constituting Vol. 275 (1989) Elsevier Sequoia S.A.. Lausanne - Printed in The Netherlands b ' I L Electromicrobial transformations using the pyruvate synthase system of Clostridium sporogenes Neil M. Dixon, Eurig W. James, Robert W. Lovitt * and Douglas B. Kell Departmen1 o/ Biological Sciences, University College of IVules, Aberystwylh, Djfed SY23 3DA (Great Britain) (Received 3 December 1988; in revised form 17 January 1989) I I J A bioelectrochemical method by which the enzymology of reductive carboxylations (RCOOH +C02 +6 [H]+RCH2COOH+2 H,O) could be investigated is described. This method was used for a I detailed study of the enynnology of the overall reaction (viz. acetyl phosphate to pyruvate) catalysed by I pyruvate synthase in Clostridium sporogenes. The same method could be utilised to harness such reductive I carboxylations for commercial biotransformations of xenobiotics. By adjusting the reaction conditions it was possible to alter the proportions of the products synthesised, and to synthesise compounds more reduced and/or with a greater number of carbon atoms than pyruvate. INTRODUCTION ! The proteolytic clostridia have been the subject of renewed interest, with the attention being focussed upon biotechnologically useful enyzmes that these I organisms produce. Apart from extracellular hydrolases, most notable are enoate [I-41, nitroaryl [5],linoleate [6],2-oxoacid [7], proline [8] and glycine reductases [9]. Recent investigations in this laboratory have concentrated upon Clostridiunz sporo- 1 genes[lO-171. Dixon [I71 detailed the effects of CO, on both the inhibition/stimulation and induction/repression of some of the "capnic" enzymes of CI.
    [Show full text]
  • 1 Studies on 3-Hydroxypropionate Metabolism in Rhodobacter
    Studies on 3-Hydroxypropionate Metabolism in Rhodobacter sphaeroides Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Steven Joseph Carlson Graduate Program in Microbiology The Ohio State University 2018 Dissertation Committee Dr. Birgit E. Alber, Advisor Dr. F. Robert Tabita Dr. Venkat Gopalan Dr. Joseph A. Krzycki 1 Copyrighted by Steven Joseph Carlson 2018 2 Abstract In this work, the involvement of multiple biochemical pathways used by the metabolically versatile Rhodobacter sphaeroides to assimilate 3-hydroxypropionate was investigated. In Chapter 2, evidence of a 3-hydroxypropionate oxidative path is presented. The mutant RspdhAa2SJC was isolated which lacks pyruvate dehydrogenase activity and is unable to grow with pyruvate. Robust 3-hydropropionate growth with RspdhAa2SJC indicated an alternative mechanism exists to maintain the acetyl-CoA pool. Further, RsdddCMA4, lacking the gene encoding a possible malonate semialdehyde dehydrogenase, was inhibited for growth with 3-hydroxypropionate providing support for a 3-hydroxypropionate oxidative pathway which involves conversion of malonate semialdehyde to acetyl-CoA. We propose that the 3- hydroxypropionate growth of RspdhAa2SJC is due to the oxidative conversion of 3- hydroxypropionate to acetyl-CoA. In Chapter 3, the involvement of the ethylmalonyl-CoA pathway (EMCP) during growth with 3-hydroxypropionate was studied. Phenotypic analysis of mutants of the EMCP resulted in varying degrees of 3-hydroxypropionate growth. Specifically, a mutant lacking crotonyl-CoA carboxylase/reductase grew similar to wild type with 3- hydroxypropionate. However, mutants lacking subsequent enzymes in the EMCP exhibited 3-hydroxypropionate growth defects that became progressively more severe the ii later the enzyme participated in the EMCP.
    [Show full text]
  • Supplement 1 Overview of Dystonia Genes
    Supplement 1 Overview of genes that may cause dystonia in children and adolescents Gene (OMIM) Disease name/phenotype Mode of inheritance 1: (Formerly called) Primary dystonias (DYTs): TOR1A (605204) DYT1: Early-onset generalized AD primary torsion dystonia (PTD) TUBB4A (602662) DYT4: Whispering dystonia AD GCH1 (600225) DYT5: GTP-cyclohydrolase 1 AD deficiency THAP1 (609520) DYT6: Adolescent onset torsion AD dystonia, mixed type PNKD/MR1 (609023) DYT8: Paroxysmal non- AD kinesigenic dyskinesia SLC2A1 (138140) DYT9/18: Paroxysmal choreoathetosis with episodic AD ataxia and spasticity/GLUT1 deficiency syndrome-1 PRRT2 (614386) DYT10: Paroxysmal kinesigenic AD dyskinesia SGCE (604149) DYT11: Myoclonus-dystonia AD ATP1A3 (182350) DYT12: Rapid-onset dystonia AD parkinsonism PRKRA (603424) DYT16: Young-onset dystonia AR parkinsonism ANO3 (610110) DYT24: Primary focal dystonia AD GNAL (139312) DYT25: Primary torsion dystonia AD 2: Inborn errors of metabolism: GCDH (608801) Glutaric aciduria type 1 AR PCCA (232000) Propionic aciduria AR PCCB (232050) Propionic aciduria AR MUT (609058) Methylmalonic aciduria AR MMAA (607481) Cobalamin A deficiency AR MMAB (607568) Cobalamin B deficiency AR MMACHC (609831) Cobalamin C deficiency AR C2orf25 (611935) Cobalamin D deficiency AR MTRR (602568) Cobalamin E deficiency AR LMBRD1 (612625) Cobalamin F deficiency AR MTR (156570) Cobalamin G deficiency AR CBS (613381) Homocysteinuria AR PCBD (126090) Hyperphelaninemia variant D AR TH (191290) Tyrosine hydroxylase deficiency AR SPR (182125) Sepiaterine reductase
    [Show full text]
  • Fifth Southeast Enzyme Conference Saturday, April 5, 2014
    Saturday,April5,2014 Georgia State University Atlanta, GA Urban Life Building College of Law 140 Decatur Street Room 220 1 2 Fifth Southeast Enzyme Conference Saturday, April 5, 2014 Sponsored by generous contributions from: Department of Biochemistry, Cellular Department of Chemistry and Molecular Biology Georgia State University University of Tennessee, Knoxville Department of Biology Office of Research Engagement Georgia State University University of Tennessee, Knoxville Additional support provided by College of Arts and Sciences Anonymous donors to the SEC University of Tennessee, Knoxville Foundation Account. To become one yourself, see details on the next page. 3 Southeast Enzyme Conference Fund- 020183 The Chemistry Department at Georgia State University is the lead organizer and founder of the Southeast Enzyme Conference. This conference attracts students, research scientists and faculty members from colleges and universities throughout the southeastern region. With the assistance of the GSU Foundation, conference organizers are seeking charitable contributions to help sustain future conferences. Gifts will be used to cover conference-related expenses such as speaker fees, public relations and marketing, material and supplies, awards and administrative costs. Please consider making a charitable, tax-deductible donation to help achieve the goal. Donor(s) name(s) – First, Middle, Last Name (s) Street Address City State Zip Home Phone Cell Phone Preferred E-mail Address Outright Gift I/we would like to make a gift to the Georgia State University Foundation in the amount of $ _____ My check is enclosed. ____ Charge my credit card upon receipt (see information below). *Please make checks payable to GSU Foundation Annual Pledge I/we would like to pledge a total of $ ______________ to the Georgia State University Foundation over a period of _____ month(s).
    [Show full text]
  • 1 Silencing Branched-Chain Ketoacid Dehydrogenase Or
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Silencing branched-chain ketoacid dehydrogenase or treatment with branched-chain ketoacids ex vivo inhibits muscle insulin signaling Running title: BCKAs impair insulin signaling Dipsikha Biswas1, PhD, Khoi T. Dao1, BSc, Angella Mercer1, BSc, Andrew Cowie1 , BSc, Luke Duffley1, BSc, Yassine El Hiani2, PhD, Petra C. Kienesberger1, PhD, Thomas Pulinilkunnil1†, PhD 1Department of Biochemistry and Molecular Biology, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada, 2Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada. †Correspondence to Thomas Pulinilkunnil, PhD Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University Dalhousie Medicine New Brunswick, 100 Tucker Park Road, Saint John E2L4L5, New Brunswick, Canada. Telephone: (506) 636-6973; Fax: (506) 636-6001; email: [email protected]. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International
    [Show full text]
  • SUPPY Liglucosexlmtdh
    US 20100314248A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0314248 A1 Worden et al. (43) Pub. Date: Dec. 16, 2010 (54) RENEWABLE BOELECTRONIC INTERFACE Publication Classification FOR ELECTROBOCATALYTC REACTOR (51) Int. Cl. (76) Inventors: Robert M. Worden, Holt, MI (US); C25B II/06 (2006.01) Brian L. Hassler, Lake Orion, MI C25B II/2 (2006.01) (US); Lawrence T. Drzal, Okemos, GOIN 27/327 (2006.01) MI (US); Ilsoon Lee, Okemo s, MI BSD L/04 (2006.01) (US) C25B 9/00 (2006.01) (52) U.S. Cl. ............... 204/403.14; 204/290.11; 204/400; Correspondence Address: 204/290.07; 427/458; 204/252: 977/734; PRICE HENEVELD COOPER DEWITT & LIT 977/742 TON, LLP 695 KENMOOR, S.E., PO BOX 2567 (57) ABSTRACT GRAND RAPIDS, MI 495.01 (US) An inexpensive, easily renewable bioelectronic device useful for bioreactors, biosensors, and biofuel cells includes an elec (21) Appl. No.: 12/766,169 trically conductive carbon electrode and a bioelectronic inter face bonded to a surface of the electrically conductive carbon (22) Filed: Apr. 23, 2010 electrode, wherein the bioelectronic interface includes cata lytically active material that is electrostatically bound directly Related U.S. Application Data or indirectly to the electrically conductive carbon electrode to (60) Provisional application No. 61/172,337, filed on Apr. facilitate easy removal upon a change in pH, thereby allowing 24, 2009. easy regeneration of the bioelectronic interface. 7\ POWER 1 - SUPPY|- LIGLUCOSEXLMtDH?till pi 6.0 - esses&aaaas-exx-xx-xx-xx-xxxxixax-e- Patent Application Publication Dec. 16, 2010 Sheet 1 of 18 US 2010/0314248 A1 Potential (nV) Patent Application Publication Dec.
    [Show full text]
  • Catabolic and Anabolic Enzyme Activities and Energetics of Acetone Metabolism of the Sulfate-Reducing Bacterium Desulfococcus Biacutus
    JOURNAL OF BACTERIOLOGY, Jan. 1995, p. 277–282 Vol. 177, No. 2 0021-9193/95/$04.0010 Copyright q 1995, American Society for Microbiology Catabolic and Anabolic Enzyme Activities and Energetics of Acetone Metabolism of the Sulfate-Reducing Bacterium Desulfococcus biacutus PETER H. JANSSEN* AND BERNHARD SCHINK Fakulta¨t fu¨r Biologie, Universita¨t Konstanz, D-78434 Konstanz, Germany Received 1 August 1994/Accepted 7 November 1994 Acetone degradation by cell suspensions of Desulfococcus biacutus was CO2 dependent, indicating initiation by a carboxylation reaction, while degradation of 3-hydroxybutyrate was not CO2 dependent. Growth on 3-hydroxybutyrate resulted in acetate accumulation in the medium at a ratio of 1 mol of acetate per mol of substrate degraded. In acetone-grown cultures no coenzyme A (CoA) transferase or CoA ligase appeared to be involved in acetone metabolism, and no acetate accumulated in the medium, suggesting that the carboxylation of acetone and activation to acetoacetyl-CoA may occur without the formation of a free intermediate. Catab- olism of 3-hydroxybutyrate occurred after activation by CoA transfer from acetyl-CoA, followed by oxidation to acetoacetyl-CoA. In both acetone-grown cells and 3-hydroxybutyrate-grown cells, acetoacetyl-CoA was thiolyti- Downloaded from cally cleaved to two acetyl-CoA residues and further metabolized through the carbon monoxide dehydrogenase pathway. Comparison of the growth yields on acetone and 3-hydroxybutyrate suggested an additional energy requirement in the catabolism of acetone. This is postulated to be the carboxylation reaction (DG&* for the carboxylation of acetone to acetoacetate, 117.1 kJ z mol21). At the intracellular acyl-CoA concentrations measured, the net free energy change of acetone carboxylation and catabolism to two acetyl-CoA residues would be close to 0 kJ z mol of acetone21, if one mol of ATP was invested.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Peter D Karp Ingrid Keseler An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Anamika Kothari Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000789375Cyc: Thermotoga sp. Cell2 Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]
  • Dynamic Control Over Feedback Regulation Identifies Pyruvate-Ferredoxin Oxidoreductase As a Central Metabolic Enzyme in Stationary Phase E
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.26.219949; this version posted August 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamic control over feedback regulation identifies pyruvate-ferredoxin oxidoreductase as a central metabolic enzyme in stationary phase E. coli. ​ 1,* 2,* 2 2 2,3, + Shuai Li ,​ Zhixia Ye ,​ Juliana Lebeau ,​ Eirik A. Moreb ,and​ Michael D. Lynch 1 ​ ​ ​ ​ ​ Department​ of Chemistry, Duke University 2 Department​ of Biomedical Engineering, Duke University *Authors contributed equally to this work. 3 To​ whom all correspondence should be addressed. [email protected] Abstract: We demonstrate the use of two-stage dynamic metabolic control to manipulate ​ feedback regulation in central metabolism and improve stationary phase biosynthesis in engineered E. coli. Specifically, we report the impact of dynamic control over two enzymes: ​ citrate synthase, and glucose-6-phosphate dehydrogenase, on stationary phase fluxes. Firstly, ​ ​ ​ ​ reduced citrate synthase levels lead to a reduction in 휶-ketoglutarate, which is an inhibitor of sugar transport, resulting in increased stationary phase glucose uptake and glycolytic fluxes. Reduced glucose-6-phosphate dehydrogenase activity activates the SoxRS regulon and expression of pyruvate-ferredoxin oxidoreductase, which is in turn responsible for large increases in acetyl-CoA production. The combined reduction in citrate synthase and glucose-6-phosphate dehydrogenase, leads to greatly enhanced stationary phase metabolism and ​ the improved production of citramalic acid enabling titers of 126±7g/L. These results identify pyruvate oxidation via the pyruvate-ferredoxin oxidoreductase as a “central” metabolic pathway in stationary phase E.
    [Show full text]
  • Index of Recommended Enzyme Names
    Index of Recommended Enzyme Names EC-No. Recommended Name Page 1.2.1.10 acetaldehyde dehydrogenase (acetylating) 115 1.2.1.38 N-acetyl-y-glutamyl-phosphate reductase 289 1.2.1.3 aldehyde dehydrogenase (NAD+) 32 1.2.1.4 aldehyde dehydrogenase (NADP+) 63 1.2.99.3 aldehyde dehydrogenase (pyrroloquinoline-quinone) 578 1.2.1.5 aldehyde dehydrogenase [NAD(P)+] 72 1.2.3.1 aldehyde oxidase 425 1.2.1.31 L-aminoadipate-semialdehyde dehydrogenase 262 1.2.1.19 aminobutyraldehyde dehydrogenase 195 1.2.1.32 aminomuconate-semialdehyde dehydrogenase 271 1.2.1.29 aryl-aldehyde dehydrogenase 255 1.2.1.30 aryl-aldehyde dehydrogenase (NADP+) 257 1.2.3.9 aryl-aldehyde oxidase 471 1.2.1.11 aspartate-semialdehyde dehydrogenase 125 1.2.1.6 benzaldehyde dehydrogenase (deleted) 88 1.2.1.28 benzaldehyde dehydrogenase (NAD+) 246 1.2.1.7 benzaldehyde dehydrogenase (NADP+) 89 1.2.1.8 betaine-aldehyde dehydrogenase 94 1.2.1.57 butanal dehydrogenase 372 1.2.99.2 carbon-monoxide dehydrogenase 564 1.2.3.10 carbon-monoxide oxidase 475 1.2.2.4 carbon-monoxide oxygenase (cytochrome b-561) 422 1.2.1.45 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase .... 323 1.2.99.6 carboxylate reductase 598 1.2.1.60 5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase . 383 1.2.1.44 cinnamoyl-CoA reductase 316 1.2.1.68 coniferyl-aldehyde dehydrogenase 405 1.2.1.33 (R)-dehydropantoate dehydrogenase 278 1.2.1.26 2,5-dioxovalerate dehydrogenase 239 1.2.1.69 fluoroacetaldehyde dehydrogenase 408 1.2.1.46 formaldehyde dehydrogenase 328 1.2.1.1 formaldehyde dehydrogenase (glutathione)
    [Show full text]
  • Investigation of the Anabolic Pyruvate Oxidoreductase And
    INVESTIGATION OF THE ANABOLIC PYRUVATE OXIDOREDUCTASE AND THE FUNCTION OF POREF IN METHANOCOCCUS MARIPALUDIS by WINSTON CHI-KUANG LIN (under the direction of WILLIAM B. WHITMAN) ABSTRACT The pyruvate oxidoreductase (POR) catalyzes the reversible oxidation of pyruvate. For hydrogenotrophic methanogens, the anabolic POR catalyses the energetically unfavorable reductive carboxylation of acetyl-CoA to form pyruvate, a precursor of organic carbon synthesized in methanogens. Previously, the methanoccocal POR was purified to homogeneity. It contained five polypeptides, four of which were found to be similar to the four subunit (a, b, d, and g) POR. For further characterization, the por gene cluster was isolated and sequenced. Six open reading frames were found, porABCDEF. The gene porE encoded the fifth subunit that copurified with the POR. Also identified was porF, which was similar to porE. Both porE and porF contained high cysteinyl residue content and two Fe/S binding motifs, suggesting that porE and porF may serve as electron carriers for the methanococcal POR. To further elucidate the role of PorE and PorF, a deletional mutant strain JJ150 was constructed which lacked porEF. Growth of the mutant in minimal McN medium was slower than the growth of the wild type strain JJ1. POR, hydrogenase, and carbon monoxide dehydrogenase activities in JJ150 were similar to the wild type. In contrast, pyruvate-dependent methanogenesis was inhibited in JJ150. Complementation of the mutant with porEF restored growth and pyruvate-dependent methanogenesis to wild type levels. Partial complementation of porE or porF yielded different results. Partial complementation with porE restored methanogenesis but not growth. Complementation with porF did not restore methanogenesis but did partially restore growth.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]